WilmerHale Partners Lia Der Marderosian and Jonathan Wolfman presented to MassBio's General Counsel Executive Group at their quarterly roundtable event series on the topic “Corporate Governance at Small- and Mid-Cap Life Sciences Companies."

While a significant disparity continues to exist between the governance practices of large-cap vs. other public companies, mid- and small-cap companies are under increased scrutiny as a result of several legal and regulatory factors. Lawyers from WilmerHale discussed evolving standards and trend data with respect to governance issues that are typically raised by institutional shareholders with mid- and small-cap life sciences companies.